The Scientist - Home

University of Wollongong epidemiologist Gideon Meyerowitz-Katz speaks with The Scientist about his team’s finding that flawed and fraudulent COVID-19 research continues to be cited.

Multiple lines of evidence contradict the idea that the disease came to Europe via trans-Atlantic exchange.

The biotech company Verve Therapeutics launched the study with the aim of using base editing to treat a genetic condition that causes high cholesterol and increases a person's risk of developing cardiovascular disease.

Ultraviolet radiation leads to secretion of an appetite-boosting hormone in male mice, but experts say it’s not yet clear whether the mechanism applies to humans.

There is only one week remaining to submit your new product to vie for a coveted spot in The Scientist’s 2022 competition.

A new precision medicine approach is making life sweeter for infants unable to metabolize milk sugar.

A new benchtop microfluidic device generates patient-derived tumor micro-organospheres that allow for real-time cancer therapy decisions.

A study finds that roots grow deeper than typical into southeastern pocket gophers tunnel networks, raising the possibility that the rodents cultivate their food.

Preliminary testing indicates that the two people died from the Ebola-like virus, the World Health Organization says.

Head and neck cancer cells lacking the peptide involved in energy production were less likely to metastasize in mice.

IgA antibodies appear to bind to specific species of commensal gut bacteria in mice, according to a study.

Fossil findings shed light on a little-known group of Cretaceous-era beasts—and indicate that the combination of a large head and diminutive arms was no evolutionary fluke.